Norveška -
norveški -
Statens legemiddelverk
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
Norveška -
norveški -
Statens legemiddelverk
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
Norveška -
norveški -
Statens legemiddelverk
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
Norveška -
norveški -
Statens legemiddelverk
esomeprazole accord 40 mg
accord healthcare b.v. - esomeprazolnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 40 mg
Norveška -
norveški -
Statens legemiddelverk
spersallerg 0.5 mg/ ml / 0.4 mg/ ml
laboratoires théa s.a.s - antazolinhydroklorid / tetryzolinhydroklorid - Øyedråper, oppløsning med konserveringsmiddel - 0.5 mg/ ml / 0.4 mg/ ml
Europska Unija -
norveški -
EMA (European Medicines Agency)
rybrevant
janssen-cilag international n.v. - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
Norveška -
norveški -
Statens legemiddelverk
hydroxyzine bluefish 25 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg
Norveška -
norveški -
Statens legemiddelverk
hydroxyzine bluefish 10 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
Norveška -
norveški -
Statens legemiddelverk
hydroxyzine orifarm 10 mg
orifarm generics a/s - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
Norveška -
norveški -
Statens legemiddelverk
hydroxyzine orifarm 25 mg
orifarm generics a/s - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg